Thursday, July 08, 2021 2:55:19 AM
so where to next...
If we get great news at any time... no reason to think it wouldnt surge back up to 30 dollars again.and if its really good, could refocus on those higher targets from the previous rally blast that though it stopped at 31.50, had technical targets at 35 area and 45 area.
I wouldnt want to start guessing yet about that kind of rally, because what we have been watching for a few days now, is the pullback and the first stretch of rally, in a different zone, from 22.70 to 25.70/26..area and the pullback that has held so far at 24, right on track so far. that pattern is still playing out with a resistance step around 25 now to watch out for . we could see a move upward of 3 to 5 dollars or a move down of 3 to 5 dollars. 24 to 27/28 or 25 down to 22/21/20 as the patterns havent given their clue yet when they sit in a balance zone waiting, and this 25 area is one of those balance areas that has to break in some direction. Its technically looking bullish to see 24 holding. but the rally math target was reached at 26 and the sell off shows this to be correct. These targets in both directions can be seen days ahead of time, once a bottom happens and once a top happens, you just do the Fib math and see what things look like. When the price action is running along technical tracks like this, the Fib math seems to offer pretty good clues to watch for.
If we get great news at any time... no reason to think it wouldnt surge back up to 30 dollars again.and if its really good, could refocus on those higher targets from the previous rally blast that though it stopped at 31.50, had technical targets at 35 area and 45 area.
I wouldnt want to start guessing yet about that kind of rally, because what we have been watching for a few days now, is the pullback and the first stretch of rally, in a different zone, from 22.70 to 25.70/26..area and the pullback that has held so far at 24, right on track so far. that pattern is still playing out with a resistance step around 25 now to watch out for . we could see a move upward of 3 to 5 dollars or a move down of 3 to 5 dollars. 24 to 27/28 or 25 down to 22/21/20 as the patterns havent given their clue yet when they sit in a balance zone waiting, and this 25 area is one of those balance areas that has to break in some direction. Its technically looking bullish to see 24 holding. but the rally math target was reached at 26 and the sell off shows this to be correct. These targets in both directions can be seen days ahead of time, once a bottom happens and once a top happens, you just do the Fib math and see what things look like. When the price action is running along technical tracks like this, the Fib math seems to offer pretty good clues to watch for.
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
